Search Results - "O. V. Muslimova"

Retrospective Analysis of the Initial Empirical Antibiotic Therapy Effectiveness for Community-Acquired Pneumonia in Young Individuals in Moscow Multidisciplinary Hospital by O. V. Muslimova, M. V. Zhuravleva, O. A. Demidova, G. I. Gorodetskaya, A. V. Shapchenko, E. A. Sokova

“…Despite the fact that the incidence of community-acquired pneumonia (CAP) among young people is significantly lower than among older patients, the frequency of…”
Get full text

Effect of Organic Anion Transporters on the Development of Nephrotoxicity in the Context of NSAIDs Use by Muslimova, O. V., Evteev, V. A., Mazerkina, I. A.

“…Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used worldwide as pain relievers, antipyretics, and anti-inflammatory drugs. Failure to comply with…”
Get full text

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia by Muslimova, O. V., Sokova, E. A., Prokofiev, A. B., Zhuravleva, M. V., Shapchenko, A. V., Alexandrova, T. V.

“…Lower respiratory tract infections, which include community-acquired pneumonia (CAP), are the most common cause of death among all infectious diseases. The…”
Get full text

Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections by Gorodetskaya, G. I., Prokofiev, A. B., Serebrova, S. Yu, Demchenkova, E. Yu, Zhuravleva, M. V., Demidova, O. A., Alexandrova, T. V., Mazerkina, I. A., Sokova, E. A., Muslimova, O. V.

“…Cephalosporins are the empirical antibiotic therapy (ABT) of choice for patients with community-acquired pneumonia (CAP). When treated with antibiotics,…”
Get full text

Some Aspects of Drug Induced Nephrotoxicity Assessment by Sokova, E. A., Arkhipov, V. V., Mazerkina, I. A., Muslimova, O. V.

“…About 14‒23% of all clinically used drugs have nephrotoxic potential and are a frequent cause of acute and chronic kidney problems. Acute kidney injury (AKI)…”
Get full text

Experimental Cell Line Models for Nephrotoxicity Screening by Mazerkina, I. A., Evteev, V. A., Prokofiev, A. B., Muslimova, O. V., Demchenkova, E. Yu

“…The aim of the study was to review literature data on cell models for experimental assessment of drug nephrotoxicity in vitro . Because of nephrotoxicity, 2%…”
Get full text

Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People by Alexandrova, T. V., Muslimova, O. V., Zhuravleva, M. V., Alexandrov, A. A., Gorodetskaya, G. I., Demchenkova, E. Yu, Demidova, O. A., Sokova, E. A., Mazerkina, I. A., Smirnova, Yu. А.

“…β-lactam antibiotics, including cephalosporins, are the drugs of choice for empirical antibiotic therapy (ABT) in patients with community-acquired pneumonia…”
Get full text

Nephrotoxicity Biomarkers: Role and Significance in the Diagnosis of Drug-Induced Kidney Injury by Muslimova, O. V., Evteev, V. A., Mazerkina, I. A., Sokova, E. A., Prokofiev, A. B., Shapchenko, A. V., Alexandrova, T. V.

“…Drug-induced kidney injury (DIKI) accounts for 8 to 60% of episodes of acute kidney injury (AKI) among hospital patients. Early DIKI detection and timely…”
Get full text

β-Lactam Antibiotics—Drug-Drug Interaction Mediated by Organic Anion Transporters OAT1 and OAT3 by Mazerkina, I. A., Evteev, V. A., Prokofiev, A. B., Muslimova, O. V., Demchenkova, E. Yu

“…Organic anion transporters OAT1 and OAT3 play a key role in elimination of most β-lactam antibiotics. Since nonsteroidal anti-inflammatory drugs, antivirals,…”
Get full text

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance by Zhuravleva, M. V., Romanov, B. K., Gorodetskaya, G. I., Muslimova, O. V., Krysanova, V. S., Demchenkova, E. Yu

“…Since 2010, Russia has been developing new drug legislation, internal quality control and safety of medical organizations, and has developed algorithms for…”
Get full text

Clinical case of rheumatoid arthritis with antiphospholipid antibody syndrome by Arabidze, G. G, Shapchenko, A. V, Muslimova, O. V, Larina, O. Yu, Sorokoletov, A. M

“…The article presents a clinical case of development of secondary antiphospholipid syndrome (APS) with early active rheumatoid polyarthritis, complication in…”
Get full text

Organo-protective effects of quinapril: pharmacogenetic aspects by Sychev, D. A., Muslimova, O. V.

“…The review presents current experimental and clinical evidence on organo-protective effects of an ACE inhibitor quinapril. These effects are dependent on I/D…”
Get full text

Organic anion transporters and their influence on the toxicity of β-lactam antibiotics by V. A. Evteev, O. V. Muslimova, I. A. Mazerkina, N. D. Bunyatyan, E. V. Shikh, R. E. Kazakov

“…This review article describes the classification and mechanism of action of organic anion transporters (OAT). The influence of certain members of this family…”
Get full text

Prospects of using C3435T polymorphism in the ABCB1 gene encoding P-glycoprotein in personalised medicine by R. E. Kazakov, V. A. Evteev, O. V. Muslimova, I. A. Mazerkina, E. Yu. Demchenkova, E. V. Shikh

“…The article reviews scientific literature on C3435T polymorphism in the ABCB1 gene which encodes P-glycoprotein (an ATP-binding cassette transporter which is…”
Get full text

Interchangeability of levothyroxine sodium tablets by G. I. Gorodetskaya, E. A. Sokova, O. V. Muslimova, T. V. Aleksandrova, I. A. Mazerkina, S. G. Rudnev

“…The article reviews scientific literature and regulatory documents on safe and efficacious use of levothyroxine medicines. Levothyroxine has less than a…”
Get full text

Interchangeability of glibenclamide-containing drugs by G. I. Gorodetskaya, E. V. Shikh, M. V. Zhuravleva, S. Yu. Serebrova, E. A. Sokova, O. V. Muslimova, T. V. Aleksandrova, I. A. Mazerkina, S. G. Rudnev

“…The article analyses the problem of interchangeability of glibenclamide-containing drugs that sometimes lack therapeutic equivalence even though their…”
Get full text

Pharmacogenetic testing in the treatment of type 2 diabetes with sulfonylurea drugs by G. I. Gorodetskaya, V. G. Kukes, S. A. Belkov, R. E. Kazakov, S. Yu. Serebrova, O. V. Muslimova, T. A. Rodina, A. A. Aleksandrov

“…The article analyses scientific literature on the use of pharmacogenetic testing to optimize sulfonylurea treatment of patients with type 2 diabetes. It…”
Get full text